Skip to main content

Carbidopa and Levodopa

NDC 67046-1614 · Coupler LLC

Generic nameCarbidopa and Levodopa
Dosage formTABLET
RouteORAL
Active ingredient(s)CARBIDOPA, LEVODOPA
Strength10; 100 mg/1; mg/1
Pharmacologic classAmino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]
Marketing categoryANDA

Packages

67046-1614-3 — 30 TABLET in 1 BLISTER PACK (67046-1614-3)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

64896-661 — Carbidopa and Levodopa, 64896-662 — Carbidopa and Levodopa, 64896-663 — Carbidopa and Levodopa, 64896-664 — Carbidopa and Levodopa, 64896-967 — carbidopa and levodopa, 64896-968 — carbidopa and levodopa, 64896-969 — carbidopa and levodopa, 64896-970 — carbidopa and levodopa, 67046-1450 — Carbidopa and Levodopa, 67046-1507 — carbidopa and levodopa, 67046-1668 — Carbidopa and Levodopa, 67046-1689 — Carbidopa and Levodopa, 68002-100 — carbidopa and levodopa, 68071-2240 — CARBIDOPA AND LEVODOPA, 68682-200 — Carbidopa Tablets, 69367-338 — Carbidopa and Levodopa, 69367-339 — Carbidopa and Levodopa, 69367-340 — Carbidopa and Levodopa, 70518-4610 — Carbidopa and Levodopa, 70518-4618 — Carbidopa and Levodopa, +147 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels